Home›Stock Screener›Ajanta Pharma›Quarterly Results

Ajanta Pharma Quarterly Results

Latest Quarter Net Profit
₹388 Cr
QSept 2026
Quarterly Results

Ajanta Pharma quarterly results. In Sept 2026, Ajanta Pharma (AJANTPHARM) reported revenue ₹1,832 Cr and net profit ₹388 Cr — revenue +29.7% YoY. For annual financials, live price and key ratios, visit Ajanta Pharma stock price NSE.

AJANTPHARM Quarterly Results — Revenue, Profit & EPS Highlights

Ajanta Pharma latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. View AJANTPHARM 52-week performance for the annual high/low range and current price position.

  • Revenue of ₹1,832 Cr in Sept 2026 (+23.5% vs Mar 2026, +29.7% vs Sept 2025)
  • Net Profit of ₹388 Cr in Sept 2026 (+45.3% vs Mar 2026, +49.2% vs Sept 2025)
  • EBITDA of ₹585 Cr in Sept 2026 (+48.1% vs Mar 2026)
  • Operating Margin of 31.0% in Sept 2026 (+8.0pp vs Mar 2026)
  • Earnings Per Share of ₹31.07 in Sept 2026 (+45.5% vs Mar 2026)

Ajanta Pharma Quarterly Results — Revenue, EBITDA, Net Profit & EPS

AJANTPHARM quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2026 Mar 2026 Jun 2026 Sept 2025 Mar 2025 QoQ YoY
Revenue (₹ Cr) 1,832 1,483 1,697 1,413 1,189 23.5% 29.7%
Net Profit (₹ Cr) 388 267 334 260 225 - -
EBITDA (₹ Cr) 585 395 495 387 315 - -
EPS (₹) 31.07 21.35 26.75 20.83 18.00 - -
Operating Margin (%) 31.0% 23.0% 26.0% 24.0% 25.0% - -

AJANTPHARM Share Price Trend — 1-Year Movement Across Quarterly Results

Ajanta Pharma 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Also explore Ajanta Pharma share price performance to track price trends across different timeframes.

Profitability Ratios

Profit Margin 21.2%
EBITDA Margin 31.9%
Operating Margin 31.0%
ROE (Annual) 34.3%

Balance Sheet Highlights

Total Assets ₹6,155 Cr
Total Equity ₹4,527 Cr
Current Assets ₹ Cr
Current Liabilities ₹212 Cr

Cash Flow Analysis

Operating Cash Flow ₹529 Cr
Investing Cash Flow ₹-429 Cr
Financing Cash Flow ₹-168 Cr
Net Cash Flow ₹-68 Cr

Current Market Data

Current Price ₹3270.30
Exchange NSE
Last Updated Nov 19, 2026

AJANTPHARM vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Ajanta Pharma latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2026
₹451,074.97 Cr 1900.0 16,617 1,995 +10.6% - 12.0% 228.9
Divis Laboratories
Sept 2026
₹294,139.19 Cr 11178.0 3,770 1,127 +26.3% - 29.9% 263.1
Torrent Pharmaceuti…
Mar 2026
₹188,719.51 Cr 4611.0 4,111 364 +27.7% +42.2% 8.9% 400.6
Apollo Hospitals
Sept 2026
₹126,832.45 Cr 8738.0 7,673 660 +15.2% - 8.6% 199.4
Laurus Labs
Sept 2026
₹125,946.78 Cr 2306.0 2,219 436 +21.7% - 19.6% 282.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores